Skip to main content
Premium Trial:

Request an Annual Quote

JMS Realty Trust, B&H Group Limited, NAI Hunneman Commercial, 9 Centennial Drive, 10 Technology Drive

Sale of Two Peabody, Mass., Buildings Fetches $12.1M for JMS Realty Trust
Two Peabody, Mass., buildings suitable for R&D use have been sold by James Salah’s JMS Realty Trust of Dedham, Mass., to B&H Group Limited for $12.1 million, in a deal announced by the commercial real estate brokerage involved in the sale.
NAI Hunneman Commercial represented JMS in the sale of the buildings, which total 126,801 square feet. Acquired by B&H were 9 Centennial Drive, a two-story, 75,000 square-foot office building suitable for office or R&D use; and 10 Technology Drive, a single-story, 51,000 square-foot office/warehouse building also suitable for R&D use. Both buildings are within the 307-acre, 45-building Centennial Park, developed in the 1980s by the Peabody Community Development Authority and located off Route 128.
10 Technology Drive was completed in 1980 and 9 Centennial Drive, six years later.
Four NAI Hunneman professionals represented JMS: Peter Benke, executive vice president; David Ross, executive vice president/principal; Dan McGee, financial analyst; and Jeffrey Becker senior vice president. B&H represented itself in the transaction.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.